NLSP - NLS Pharmaceutics AG - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

NLSP is currently covered by 1 analysts with an average price target of $3.23. This is a potential upside of $3.09 (2207.14%) from yesterday's end of day stock price of $0.14.

NLS Pharmaceutics AG's activity chart (see below) currently has 0 price targets and 3 ratings on display. The stock rating distribution of NLSP is 66.67% HOLD and 33.33% BUY.

Stock Analyst Price Targets - Review

Highest price target for NLSP is $1, Lowest price target is $1, average price target is $3.23.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 14-Sep-2023. First documented stock forecast 08-Nov-2022.

Best performing analysts who are covering NLSP - NLS Pharmaceutics AG:

Jason Mccarthy

Currently out of the existing stock ratings of NLSP, 2 are a HOLD (66.67%), 1 are a BUY (33.33%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Jason Mccarthy (MAXIM GROUP)

Hold

7 months 5 days ago

0/1 (0%)

$3.09 (339.56%)

Please subscribe to see the analyst performance score

Show more analysts

Load Price Targets and Ratings Chart

To gain access for the analyst/ stock price target chart please use a computer

What is NLSP (NLS Pharmaceutics AG) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on NLSP (NLS Pharmaceutics AG) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on NLSP (NLS Pharmaceutics AG)?

Jason Mccarthy works at MAXIM GROUP and has 2 price targets and 2 ratings on NLSP

Which analyst is the currently most bullish on NLSP (NLS Pharmaceutics AG)?

Jason Mccarthy with highest potential upside - $0